Project Description

Dr Carhart-Harris moved to Imperial College London after obtaining his PhD in psychopharmacology from the University of Bristol in 2009. At Imperial, he led a series of brain imaging studies into the brain effects of LSD, psilocybin (magic mushrooms), MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant major depression. Three of his papers ranked within the top 100 most impactful scientific publications of the last two years (Altmetric). He is Founder and Head of the Psychedelic Research Group at Imperial and Co-founder of Global Psychedelic Research (